You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hepatic artery infusion chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Guangzhou (Hepatic artery infusion chemo(HAIC), Durvalumab)

Recruiting
  • Hepatocellular Carcinoma
  • Hepatic artery infusion chemotherapy（HAIC）
  • Durvalumab
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
May 18, 2022

Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • TACE-HACI, plus atezolizumab-bevacizumab
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 20, 2023

Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC(FOLFOX)
  • +5 more
  • (no location specified)
Aug 16, 2022

Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • TACE and HAIC Combined With Regorafenib
  • Guangzhou, Guangdong, China
    the first affiliated hospital, Sun-Yat sen university
Oct 2, 2023

Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemo Trial in Chongqing (Esketamine,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jun 9, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 4, 2023

Hepatocellular Carcinoma Trial (Donafenib, Sintilimab, HAIC)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Dec 21, 2021

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

Hepatocellular Carcinoma Trial in Shanghai (Hepatic artery infusion chemo with FOLFOX regimens (oxaliplatin, fluorouracil, and

Recruiting
  • Hepatocellular Carcinoma
  • Hepatic artery infusion chemotherapy with FOLFOX regimens (oxaliplatin, fluorouracil, and leucovorin)
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Aug 7, 2021

Sequential Regorafenib Plus ICIs After HAIC for Advanced

Recruiting
  • Hepatocellular Carcinoma
  • Regorafenib combine with ICIs
  • Guangzhou, Guangdong, China
  • +1 more
Oct 15, 2022

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Sintilimab, Bevacizumab Biosimilar)

Recruiting
  • Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Jan 16, 2022

Colorectal Cancer, Liver Metastases, Colorectal Adenocarcinoma Trial run by the NCI (device, drug, procedure)

Recruiting
  • Colorectal Cancer
  • +4 more
  • Codman 3000 constant flow pump catheter
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Carcinoma, Carcinoma, Hepatocellular, Liver Tumors Trial in Guangzhou (Hepatic arterial infusion chemo, Folfox Protocol,

Not yet recruiting
  • Carcinoma
  • +8 more
  • Hepatic arterial infusion chemotherapy
  • +2 more
  • Guangzhou, Guangdong, China
    Lei Zhang
Sep 22, 2021

Therapeutic Effects and Clinical Prognosis After HAIC for

Recruiting
  • Hepatocellular Carcinoma
  • Search of factors predicting therapeutic effects and prognosis
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
Jun 7, 2022

Hepatocarcinoma Trial in Shanghai (HAIC+TQB2450+Anlotinib)

Recruiting
  • Hepatocarcinoma
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 27, 2022

Hepatocellular Carcinoma Trial (Hepatic Artery Infusion Chemotherapy, Transarterial Chemoembolization, Regorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Hepatic Artery Infusion Chemotherapy
  • +3 more
  • (no location specified)
Feb 7, 2022

Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)

Not yet recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Recombinant Human Adenovirus Type 5
  • HAIC of FOLFOX
  • Beijing, Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Mar 16, 2022

Locally Advanced Hepatocellular Carcinoma Trial in Hwasun (Vax-NK/HCC)

Recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • Vax-NK/HCC
  • Hwasun, Jeollanam-do, Korea, Republic of
    Seon-Ah Ha
Sep 1, 2021

Unresectable Hepatocellular Carcinoma Trial in Beijing (Camrelizumab, HAIC, TKI)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 22, 2021

Colorectal Cancer, Liver Metastases, Chemo Effect Trial in Oslo (Floxuridine, Liver Transplantation)

Recruiting
  • Colorectal Cancer
  • +2 more
  • Oslo, Norway
    Oslo University Hospital
Jul 5, 2021

Bile Duct Tumors, Colorectal Tumors Trial in Lexington (Hepatic artery infusion pump placement using the Synchromed II pump and

Recruiting
  • Bile Duct Neoplasms
  • Colorectal Neoplasms
  • Hepatic artery infusion pump placement using the Synchromed II pump and the Codman tapered arterial catheter.
  • +3 more
  • Lexington, Kentucky
    University of Kentucky
Jun 20, 2021

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1

Not yet recruiting
  • HCC
  • +3 more
  • (no location specified)
Aug 28, 2021

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Patient Outcomes After Hepatic Artery Infusion Pump Placement

Recruiting
  • Colorectal Liver Metastases
  • Colorectal Cancer
    • Rochester, Minnesota
      Mayo Clinic Rochester
    Jul 18, 2022

    Recurrent Liver Cancer After Liver Transplantation Trial (Hepatic arterial infusion chemo + Atezolizumab and bevacizumab)

    Not yet recruiting
    • Recurrent Liver Cancer After Liver Transplantation
    • Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab
    • (no location specified)
    Apr 17, 2023